Genome Canada has launched a Request for Applications (RFA) on January 24, 2012, and is seeking proposals for large-scale research projects which focus on the application of genomics in the area of Genomics and Personalized Health. The competition will be a partnership with the Canadian Institutes of Health Research (CIHR) to build on the complementary mandates of Genome Canada and CIHR and provide an opportunity to maximize the effectiveness of the research communities, infrastructure and resources supported by both organizations.

<!--[if gte mso 9]> Normal 0 false false false EN-CA X-NONE X-NONE

<!--[if gte mso 9]> Normal 0 false false false EN-CA X-NONE X-NONE

With the SPARK program, the Ontario Genomics Institute (OGI) seeks to provide catalytic funding for high-impact, high-risk and/or early-stage technology development in the Genomic Sciences. The SPARK grants are intended for innovative projects which have previously not been funded and/or where funding would be difficult to obtain due to the early-stage nature of the proposed research.  Outcomes of such projects should enable follow-on investment or funding for further research or development.

17 November 2011 – 18 November 2011

89 Chestnut Street

Toronto, Ontario

This 2nd International RB meeting, organized by Dr. Eldad Zacksenhaus and Dr. Rod Bremner was held in Toronto on Nov 17th and 18th, 2011. This workshop was focused on gathering world experts in the Retinoblasoma tumor suppressor (RB) field to present recent discoveries and progress on this important tumor suppressor and to foster new ideas, collaborations and interactions.

In May 2010, Genome Canada requested applications for operations support for Science and Technology Innovation Centres (S&T ICs) in genomics technologies.  This was an open competition aimed to support competitive current and new S&T ICs for a period of two years (April 1, 2011 to March 31, 2013).

One project was funded through OGI with a total investment of $5.1 million and launched in April 2011.

Ontario project funded through S&T IC Operations Support:

On May 17, 2010, Genome Canada launched the Large Scale Applied Research Project (LSARP) competition. This competition was for applied genomics projects that had a high potential for benefits to Canada, to be realized or initiated before the end of the project. The funding for this competition was split between a focused theme on forestry and the environment and a second, multi-sector component with projects targeted to other strategic sectors (e.g. agriculture, fisheries and human health).

Joint Collaborative Program between Genome Canada and the Canadian Institutes of Health Research (CIHR): “Advancing Technology Innovation through Discovery”

Synthetic antibodies are revolutionary research tools that have already shown great potential as targeted therapeutic agents as part of the $40+ billion monoclonal antibody market. This workshop, organized by Dr.

Renaissance Hotel
Toronto, Ontario